Compare BVS & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BVS | MAGN |
|---|---|---|
| Founded | 2011 | 1864 |
| Country | United States | United States |
| Employees | N/A | 8500 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.9M | 410.8M |
| IPO Year | 2016 | N/A |
| Metric | BVS | MAGN |
|---|---|---|
| Price | $8.74 | $11.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | $14.25 | ★ $19.00 |
| AVG Volume (30 Days) | 306.1K | ★ 375.0K |
| Earning Date | 06-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 163.46 | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $568,087,000.00 | N/A |
| Revenue This Year | $7.42 | $4.09 |
| Revenue Next Year | $6.46 | $2.34 |
| P/E Ratio | $26.06 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.81 | $7.82 |
| 52 Week High | $10.13 | $19.77 |
| Indicator | BVS | MAGN |
|---|---|---|
| Relative Strength Index (RSI) | 53.99 | 25.25 |
| Support Level | $6.42 | $10.52 |
| Resistance Level | $9.01 | $12.09 |
| Average True Range (ATR) | 0.39 | 0.46 |
| MACD | -0.03 | -0.17 |
| Stochastic Oscillator | 39.63 | 3.39 |
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.